LCTX
Lineage Cell Therapeutics Inc
0.9476$
+1.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 96.7% | 98.8% | 92.9% | 95.1% | 85.9% | 90.8% | 92.4% | 94.0% | 98.1% | 98.6% | 95.1% | 80.9% | 10.5% | 92.1% | 66.8% | 54.5% | 24.1% | 13.8% | 43.3% | 49.9% | 18.0% | 24.6% | 35.8% | 45.8% | 40.8% | 63.9% | 48.5% | 38.1% | 45.0% | 52.5% | |
| 80.0% | 94.0% | 85.7% | 93.2% | 78.6% | 85.1% | 85.9% | 66.9% | 90.1% | 93.6% | 86.2% | 5.4% | 1.2% | 90.7% | 62.6% | 48.5% | 14.6% | 9.5% | 39.4% | 44.6% | 15.5% | 21.3% | 23.2% | 7.6% | 30.2% | 31.9% | 9.2% | 35.1% | 40.4% | 36.2% | |
| 80.0% | 94.0% | 85.7% | 93.2% | 78.6% | 85.1% | 85.9% | 66.9% | 90.1% | 93.6% | 86.2% | 5.4% | 1.2% | 90.7% | 62.6% | 48.5% | 14.6% | 9.5% | 39.4% | 45.4% | 15.9% | 22.0% | 30.2% | 24.5% | 38.5% | 33.4% | 46.8% | 35.1% | 42.2% | 49.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -1.0% | – | – | – | 1.9% | 1.4% | 1.7% | 0.8% | 1.8% | 3.7% | 19.7% | 0.0% | 29.3% | 0.2% | 0.7% | 0.6% | 1.4% | |
| 6.7% | 1.2% | 3.6% | – | – | – | – | – | – | – | – | – | – | 0.3% | 0.1% | 0.1% | 0.2% | 0.3% | 0.4% | 0.0% | – | 0.0% | 0.0% | 0.0% | – | – | 0.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.2% | 3.8% | 8.0% | 3.9% | 3.2% | 5.7% | 6.5% | 5.2% | 2.8% | 4.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.5% | 9.9% | 6.1% | 8.6% | 10.6% | 9.4% | 9.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 28.9% | 40.6% | 68.9% | 80.0% | 51.9% | 35.5% | 7.2% | 4.0% | 3.1% | 38.5% | 43.6% | 26.8% | 37.8% | 46.1% | 41.1% | 28.2% | |
| 6.7% | 21.7% | 14.3% | 10.5% | 21.4% | 105.1% | 178.3% | 326.8% | 77.3% | 110.0% | 386.7% | 1,839.8% | 519.8% | 17.8% | 7.2% | 9.5% | 18.3% | 26.8% | 16.3% | 19.2% | 8.5% | 5.2% | 9.3% | 11.3% | 11.9% | 47.9% | 41.8% | 38.6% | 32.0% | 61.5% | |
| 3.3% | 15.7% | 14.3% | 10.5% | 21.4% | 15.9% | 33.3% | 288.8% | 18.1% | 36.1% | 94.6% | 832.7% | 326.3% | 8.7% | 4.7% | 6.9% | 14.8% | 12.1% | 9.5% | 13.2% | 6.2% | 4.0% | 6.7% | 5.2% | 7.2% | 27.0% | 15.3% | 17.8% | 12.3% | 10.1% | |
| – | – | – | – | – | – | – | 250.6% | – | 28.9% | 66.4% | 409.2% | 182.1% | – | – | – | 9.5% | – | 0.2% | 0.1% | 0.8% | 0.2% | 0.3% | 1.0% | 1.2% | 0.5% | 0.8% | 0.9% | 1.0% | 0.8% | |
| 6.7% | 2.4% | 7.1% | 10.5% | 21.4% | 15.9% | 23.9% | 38.2% | 18.1% | 28.9% | 66.4% | 274.3% | – | – | – | 2.4% | 13.4% | 5.9% | 3.1% | 3.0% | 1.1% | 0.5% | 2.3% | 1.9% | 2.4% | 2.0% | 1.9% | 2.0% | 1.0% | 2.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.5% | 5.3% | 0.8% | 0.0% | – | – | – | – | – | – | – | – | |
| 93.3% | 78.3% | 85.7% | 89.5% | 78.6% | -5.1% | -78.3% | -226.8% | 22.7% | -10.0% | -286.7% | -1,739.8% | -419.8% | 52.5% | 71.7% | 62.5% | 81.7% | 25.6% | 48.7% | 28.4% | 82.7% | 93.9% | 92.3% | 90.0% | 89.1% | 52.8% | 59.3% | 62.8% | 69.2% | 39.6% | |
| -270.0% | -134.9% | -596.4% | -391.1% | -1,617.7% | -1,586.3% | -2,248.5% | -3,302.0% | -2,528.1% | -2,069.7% | -6,519.0% | -25,039.4% | -4,599.5% | -392.8% | -120.1% | -175.6% | -342.5% | -252.5% | -243.2% | -242.1% | -137.7% | -124.9% | -257.6% | -217.9% | -272.4% | -193.1% | -293.8% | -381.0% | -356.4% | -414.8% | |
| 277.8% | 107.0% | 357.1% | 188.2% | 658.3% | 595.6% | 826.7% | 1,330.5% | 1,147.1% | 914.0% | 3,464.7% | 13,051.4% | 2,293.7% | 218.1% | 75.6% | 102.7% | 165.4% | 93.9% | 88.7% | 84.2% | 69.8% | 66.1% | 124.8% | 116.0% | 139.0% | 94.2% | 137.3% | 170.9% | 176.8% | 204.4% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.